OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cordycepin enhances hyperthermia-induced apoptosis and cell cycle arrest by modulating the MAPK pathway in human lymphoma U937 cells
Liying Shi, He Cao, Siyu Fu, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 9, pp. 8673-8683
Closed Access | Times Cited: 8
Liying Shi, He Cao, Siyu Fu, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 9, pp. 8673-8683
Closed Access | Times Cited: 8
Showing 8 citing articles:
Application and research progress of cordycepin in the treatment of tumours (Review)
Ru He, Wence Zhou
Molecular Medicine Reports (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 3
Ru He, Wence Zhou
Molecular Medicine Reports (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 3
The therapeutic potential of natural products for treating pancreatic cancer
Xia He, Ning Wang, Yu Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Xia He, Ning Wang, Yu Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Cordycepin synergizes with CTLA-4 blockade to remodel the tumor microenvironment for enhanced cancer immunotherapy
Lujun Chen, Xiao Zheng, Hao Huang, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110786-110786
Closed Access | Times Cited: 8
Lujun Chen, Xiao Zheng, Hao Huang, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110786-110786
Closed Access | Times Cited: 8
The role and mechanisms of cordycepin in inhibiting cancer cells
Yu Gong, Jiahua Peng, Lu Li, et al.
Brazilian Journal of Medical and Biological Research (2024) Vol. 57
Open Access | Times Cited: 2
Yu Gong, Jiahua Peng, Lu Li, et al.
Brazilian Journal of Medical and Biological Research (2024) Vol. 57
Open Access | Times Cited: 2
Structural and pharmacological insights into cordycepin for neoplasms and metabolic disorders
Jinming Zhang, Ziling Yang, Zhuo Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Jinming Zhang, Ziling Yang, Zhuo Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Natural Product Cordycepin (CD) Inhibition for NRP1/CD304 Expression and Possibly SARS-CoV-2 Susceptibility Prevention on Cancers
Ting Li, Na Luo, Jiewen Fu, et al.
Microorganisms (2023) Vol. 11, Iss. 12, pp. 2953-2953
Open Access | Times Cited: 4
Ting Li, Na Luo, Jiewen Fu, et al.
Microorganisms (2023) Vol. 11, Iss. 12, pp. 2953-2953
Open Access | Times Cited: 4
Chao Sun, Jun Bai, Jingying Sun, et al.
Environmental Toxicology (2023) Vol. 39, Iss. 4, pp. 1989-2005
Closed Access | Times Cited: 2
Review of preclinical data on hyperthermia treatment in lymphomas and its potential for clinical application
Moritz V. Scharr, Frédérik Damm, P Krahl, et al.
International Journal of Hyperthermia (2024) Vol. 41, Iss. 1
Open Access
Moritz V. Scharr, Frédérik Damm, P Krahl, et al.
International Journal of Hyperthermia (2024) Vol. 41, Iss. 1
Open Access
